NSE filing, NSE: RPGLIFE. Summary written from the filing by ALFA Finder's alert engine.
RPG Life Sciences Ltd: key numbers
- Share price
- ₹3,001.00
- Market cap
- ₹4,963 Cr
- Revenue (annual)
- ₹707.5 Cr
- Net profit (annual)
- ₹115.2 Cr
- P/E (TTM)
- 41.5×Sector 46.1×
- Promoter holding
- 72.95%+0.00% QoQ
- FII holding
- 0.87%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from RPG Life Sciences Ltd
All →RPG Life Sciences Board Meeting Date
RPG Life Sciences Limited has scheduled a board meeting on October 29, 2026, to consider and approve its unaudited financial results for the quarter ending September 30, 2026.
RPG Life Sciences Other Announcement
This is the quarterly shareholding pattern filing for RPG Life Sciences Ltd for the quarter ended September 30, 2026.
RPG Life Sciences Capital Structure Change
Clarus Trust acquired 37,463 shares of RPG Life Sciences through an open market transaction. This acquisition increases the acquirer's total stake to 7.04%.
RPG Life Sciences Merger & Restructuring
RPG Life Sciences announced the amalgamation of its wholly-owned subsidiary, Actis Generics, into its other subsidiary, RPG Active Pharma Limited. No share exchange is involved.
RPG Life Sciences Acquisition
RPG Life Sciences completed its acquisition of the entire stake in Actis Generics Private Limited, making it a subsidiary of the company.
RPG Life Sciences Price Movement Clarification
RPG Life Sciences clarified that the recent increase in its trading volume is attributable to market conditions and there is no undisclosed price-sensitive information.
Other management change announcements
All →Travel Food Services Management Change
Travel Food Services appointed Avinash Yogeshwar as Senior Managerial Personnel, effective 29 October 2026. It is a senior leadership change with no financial impact.
Swan Defence and Heavy Industries Management Change
Swan Defence designated three existing employees as Senior Management Personnel effective 29 October 2026, following organisational restructuring. The move reflects leadership reorganisation, not new capital or contracts.
Prima Innovation Management Change
Prima Innovation Limited reported the resignation of Non-Executive Director Dilip M. Parekh, effective 29-10-2026, citing personal reasons. The exit is a board-level change investors should note.
Strides Pharma Science Management Change
Strides Pharma's board appointed Biren Gabhawala as Non-Executive Independent Director effective November 1, 2026, for five years. He is a Chartered Accountant with extensive audit and listed-company board experience.
- Execution
- Five-year term effective November 1, 2026
Srivasavi Adhesive Tapes Management Change
Srivasavi Adhesive Tapes appointed Ms. Venugopal as Chief Financial Officer effective 29 October 2026. She holds an MBA in Finance with seven years of finance experience.
Restaurant Brands Asia Management Change
Restaurant Brands Asia appointed nine persons on October 29, 2026, including two directors, a CEO and senior management heads. Shivkumar Dega joins as a non-executive independent director.